nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

22.03.2019

Eosinophilic Gastrointestinal Disorders

verfasst von: Nirmala Gonsalves

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Eosinophilic gastrointestinal disorders (EGID) are a group of disorders characterized by pathologic eosinophilic infiltration of the esophagus, stomach, small intestine, or colon leading to organ dysfunction and clinical symptoms (J Pediatr Gastroenterol Nutr; Spergel et al., 52: 300–306, 2011). These disorders include eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic gastroenteritis (EGE), eosinophilic enteritis (EE), and eosinophilic colitis (EC). Symptoms are dependent not only on the location (organ) as well as extent (layer invasion of the bowel wall). Common symptoms of EoE include dysphagia and food impaction in adults and heartburn, abdominal pain, and vomiting in children. Common symptoms of the other EGIDs include abdominal pain, nausea, vomiting, early satiety, diarrhea, and weight loss. These disorders are considered immune-mediated chronic inflammatory disorders with strong links to food allergen triggers. Treatment strategies focus on either medical or dietary therapy. These options include not only controlling symptoms and bowel inflammation but also on identifying potential food triggers. This chapter will focus on the clinical presentation, pathophysiology, and treatment of these increasingly recognized disorders.

Spergel JM, Book WM, Mays E, Song L, Shah SS, Talley NJ, Bonis PA (2011) Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr 52:300–306PubMedPubMedCentral

Zhang L, Duan L, Ding S, Lu J, Jin Z, Cui R, McNutt M, Wang A (2011) Eosinophilic gastroenteritis: clinical manifestations and morphological characteristics, a retrospective study of 42 patients. Scand J Gastroenterol 46:1074–1080PubMed

Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, American College of Gastroenterology (2013) ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 108:679–692 quiz 693PubMed

Erwin EA, Asti L, Hemming T, Kelleher KJ (2012) A decade of hospital discharges related to eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 54:427–429PubMedPubMedCentral

Soon IS, Butzner JD, Kaplan GG, deBruyn JCC (2013) Incidence and prevalence of eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr 57:72–80PubMed

Noel RJ, Putnam PE, Rothenberg ME (2004) Eosinophilic esophagitis. N Engl J Med 351:940–941PubMed

Hruz P, Straumann A, Bussmann C, Heer P, Simon HU, Zwahlen M, Beglinger C, Schoepfer AM, Swiss EoE study group (2011) Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol 128:1349–1350 e5PubMed

Giriens B, Yan P, Safroneeva E, Zwahlen M, Reinhard A, Nydegger A, Vavricka S, Sempoux C, Straumann A, Schoepfer AM (2015) Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993-2013: a population-based study. Allergy 70:1633–1639PubMed

Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Walker MM, Agreus L (2007) Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 56:615–620PubMed

10.

Bach J-F (2001) Protective role of infections and vaccinations on autoimmune disease. J Autoimmun 3:347–353

11.

Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, Bonis P, Hassall E, Straumann A, Rothenberg ME, First International Gastrointestinal Eosinophil Research Symposium (FIGERS) Subcommittees (2007) Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 133:1342–1363PubMed

12.

Koutlas NTES, Rusin S, Perjar I, Hollyfield J, Woosley JT, Shaheen NJ, Dellon S (2018) Impact of smoking, alcohol consumption, and NSAID use on risk for and phenotypes of eosinophilic esophagitis. Dis Esophagus 31:1–7PubMed

13.

Jensen ETKJ, Martin LJ, Rothenberg ME, Dellon ES (2018) Prenatal, intrapartum, and postnatal factors are associated with pediatric eosinophilic esophagitis. J Allergy Clin Immunol 141:214–222PubMed

14.

Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, Flick J, Kelly J, Brown–Whitehorn T, Mamula P, Markowitz JE (2005) Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 3:1198–1206

15.

Patel SM, Falchuk KR (2005) Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest Endosc 61:165–167PubMed

16.

Meyer GW (2005) Eosinophilic esophagitis in a father and a daughter. Gastrointest Endosc 61:932PubMed

17.

Alexander ES, Martin LJ, Collins MH, Kottyan LC, Sucharew H, He H, Mukkada VA, Succop PA, Abonia JP, Foote H, Eby MD, Grotjan TM, Greenler AJ, Dellon ES, Demain JG, Furuta GT, Gurian LE, Harley JB, Hopp RJ, Kagalwalla A, Kaul A, Nadeau KC, Noel RJ, Putnam PE, von Tiehl KF, Rothenberg ME (2014) Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol 134:1084–1092 e1PubMedPubMedCentral

18.

Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, Jameson SC, Kirby C, Konikoff MR, Collins MH, Cohen MB, Akers R, Hogan SP, Assa'ad AH, Putnam PE, Aronow BJ, Rothenberg ME (2006) Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116:536–547PubMedPubMedCentral

19.

Gonsalves N (2014) Distinct features in the clinical presentations of eosinophilic esophagitis in children and adults: is this the same disease? Dig Dis 32:89–92PubMed

20.

Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano I, Schoepfer AM, Simon D, Simon HU (2012) Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 67:477–490PubMed

21.

Assa'ad AH, Putnam PE, Collins MH et al (2007) Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 119:731–738PubMed

22.

Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I (2006) Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 64:313–319PubMed

23.

Collins MH, Martin LJ, Alexander ES et al (2016) Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring. Dis Esophagus

24.

Sgouros SN, Bergele C, Mantides A (2006) Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol 18:211–217PubMed

25.

Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR (2013) Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut 62:489–495PubMed

26.

Collins MH (2014) Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases. Gastroenterol Clin N Am 43:257–268

27.

Aceves SS (2011) Tissue remodeling in patients with eosinophilic esophagitis: what lies beneath the surface? J Allergy Clin Immunol 128:1047–1049PubMed

28.

Fox VL, Nurko S, Teitelbaum JE, Badizadegan K, Furuta GT (2003) High-resolution EUS in children with eosinophilic “allergic” esophagitis. Gastrointest Endosc 57:30–36PubMed

29.

Carlson DA, Hirano I, Zalewski A, Gonsalves N, Lin Z, Pandolfino JE (2017) Improvement in esophageal distensibility in response to medical and diet therapy in eosinophilic esophagitis. Clin Transl Gastroenterol 8:119

30.

Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, Burks AW, Chehade M, Collins MH, Dellon ES, Dohil R, Falk GW, Gonsalves N, Gupta SK, Katzka DA, Lucendo AJ, Markowitz JE, Noel RJ, Odze RD, Putnam PE, Richter JE, Romero Y, Ruchelli E, Sampson HA, Schoepfer A, Shaheen NJ, Sicherer SH, Spechler S, Spergel JM, Straumann A, Wershil BK, Rothenberg ME, Aceves SS (2011) Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 128:3–20 e6 quiz 21-2PubMed

31.

Fujiwara Y, Sugawa T, Tanaka F, Tatsuwaki H, Okuyama M, Hayakawa T, Yamamori K, Wada R, Ohtani K, Uno H, Tanigawa T, Watanabe Y, Tominaga K, Watanabe T, Takaishi O, Saeki Y, Nebiki H, Oshitani N, Sato H, Arakawa T (2012) A multicenter study on the prevalence of eosinophilic esophagitis and PPI-responsive esophageal eosinophilic infiltration. Intern Med 51:3235–3239PubMed

32.

Gomez Torrijos E, Rodriguez Sanchez J, Castro Jimenez A, Garcia Rodriguez R, Feo-Brito F, Molina-Infante J (2015) Proton pump inhibitor-responsive oesophageal eosinophilia (PPI-REE): characteristics of a Spanish population in Central Spain. Clin Exp Allergy 45:1367–1369PubMed

33.

Molina-Infante J, Ferrando-Lamana L, Ripoll C et al (2011) Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 9:110–117PubMed

34.

Dellon ES, Speck O, Woodward K, Covey S, Rusin S, Gebhart JH, Chen X, Woosley JT, Shaheen NJ (2014) Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol 12:2015–2022PubMedPubMedCentral

35.

Eluri S, Dellon ES (2015) Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences. Curr Opin Gastroenterol 31:309–315PubMedPubMedCentral

36.

Cheng E, Zhang X, Huo X, Yu C, Zhang Q, Wang DH, Spechler SJ, Souza RF (2013) Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut 62:824–832PubMed

37.

Schoepfer AM, Safroneeva E, Bussmann C et al (2013) Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology 145:1230–1236 e1–2PubMed

38.

Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU (2003) Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125:1660–1669PubMed

39.

Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE (2011) Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology 140:82–90PubMed

40.

Kia L, Hirano I (2015) Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies. Nat Rev Gastroenterol Hepatol 12:379–386PubMedPubMedCentral

41.

Faubion WA Jr, Perrault J, Burgart LJ, Zein NN, Clawson ML, Freese DK (1998) Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 27:90–93PubMed

42.

Remedios M, Campbell C, Jones DM, Kerlin P (2006) Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 63:3–12PubMed

43.

Lucendo AJ, Pascual-Turrion JM, Navarro M et al (2007) Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy 39:765–771PubMed

44.

Konikoff MR, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier BK, Akers R, Cohen MB, Collins MH, Assa’ad AH, Aceves SS, Putnam PE, Rothenberg ME (2006) A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 131:1381–1391PubMed

45.

Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM, Kita H, Kryzer LA, Romero Y, Smyrk TC, Talley NJ (2012) Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol 10:742–749 e1PubMed

46.

Aceves SS, Bastian JF, Newbury RO, Dohil R (2007) Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 102:2271–2279 quiz 2280PubMed

47.

Dohil R, Newbury R, Fox L, Bastian J, Aceves S (2010) Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 139:418–429PubMed

48.

Straumann A, Conus S, Degen L et al (2010) Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 139:1526–1537 1537 e1PubMed

49.

Miehlke S, Hruz P, Vieth M, Bussmann C, von Arnim U, Bajbouj M, Schlag C, Madisch A, Fibbe C, Wittenburg H, Allescher HD, Reinshagen M, Schubert S, Tack J, Müller M, Krummenerl P, Arts J, Mueller R, Dilger K, Greinwald R, Straumann A (2016) A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis. Gut 65:390–399PubMed

50.

Golekoh MC, Hornung LN, Mukkada VA, Khoury JC, Putnam PE, Backeljauw PF (2016) Adrenal insufficiency after chronic swallowed glucocorticoid therapy for eosinophilic esophagitis. J Pediatr 170:240–245PubMed

51.

Butz BK, Wen T, Gleich GJ, Furuta GT, Spergel J, King E, Kramer RE, Collins MH, Stucke E, Mangeot C, Jackson WD, O'Gorman M, Abonia JP, Pentiuk S, Putnam PE, Rothenberg ME (2014) Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology 147:324–333 e5PubMed

52.

Liacouras CA, Wenner WJ, Brown K, Ruchelli E (1998) Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 26:380–385PubMed

53.

Schaefer ET, Fitzgerald JF, Molleston JP, Croffie JM, Pfefferkorn MD, Corkins MR, Lim JD, Steiner SJ, Gupta SK (2008) Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol 6:165–173PubMed

54.

Alexander JA, Ravi K, Enders FT et al (2016) Montelukast does not maintain symptom reductions following topical steroid therapy for eosinophilic esophagitis. Clin Gastroenterol Hepatol

55.

Netzer P, Gschossmann JM, Straumann A, Sendensky A, Weimann R, Schoepfer AM (2007) Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol 19:865–869PubMed

56.

Straumann A, Hoesli S, Bussmann C, Stuck M, Perkins M, Collins LP, Payton M, Pettipher R, Hunter M, Steiner J, Simon HU (2013) Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis. Allergy 68:375–385PubMed

57.

Stein ML, Collins MH, Villanueva JM et al (2006) Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118:1312–1319PubMed

58.

Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, Beglinger C, Smith DA, Patel J, Byrne M, Simon HU (2010) Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 59:21–30PubMed

59.

Assa'ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HG, Aceves SS (2011) An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology 141:1593–1604

60.

Spergel JM, Rothenberg ME, Collins MH et al (2012) Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 129:456–463 463 e1–3

61.

Straumann A, Bussmann C, Conus S, Beglinger C, Simon HU (2008) Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol 122:425–427PubMed

62.

Rothenberg ME, Wen T, Greenberg A, Alpan O, Enav B, Hirano I, Nadeau K, Kaiser S, Peters T, Perez A, Jones I, Arm JP, Strieter RM, Sabo R, Gunawardena KA (2015) Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol 135:500–507PubMed

63.

Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA (1995) Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 109:1503–1512PubMed

64.

Peterson KA, Byrne KR, Vinson LA, Ying J, Boynton KK, Fang JC, Gleich GJ, Adler DG, Clayton F (2013) Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol 108:759–766PubMed

65.

Arias A, Gonzalez-Cervera J, Tenias JM et al (2014) Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology 146:1639–1648

66.

Molina-Infante J, Arias A, Barrio J, Rodríguez-Sánchez J, Sanchez-Cazalilla M, Lucendo AJ (2014) Four-food group elimination diet for adult eosinophilic esophagitis: a prospective multicenter study. J Allergy Clin Immunol 134:1093–1099 e1PubMed

67.

Gonsalves N, Yang GY, Doerfler B et al (2012) Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 142:1451–1459 e1; quiz e14–5PubMed

68.

Kagalwalla AF, Sentongo TA, Ritz S, Hess T, Nelson SP, Emerick KM, Melin–Aldana H, Li BUK (2006) Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 4:1097–1102PubMed

69.

Lucendo AJ, Arias A, Gonzalez-Cervera J et al (2013) Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol 131:797–804PubMed

70.

Doerfler B, Bryce P, Hirano I, Gonsalves N (2015) Practical approach to implementing dietary therapy in adults with eosinophilic esophagitis: the Chicago experience. Dis Esophagus 28:42–58PubMed

71.

Furuta GT, Kagalwalla AF, Lee JJ, Alumkal P, Maybruck BT, Fillon S, Masterson JC, Ochkur S, Protheroe C, Moore W, Pan Z, Amsden K, Robinson Z, Capocelli K, Mukkada V, Atkins D, Fleischer D, Hosford L, Kwatia MA, Schroeder S, Kelly C, Lovell M, Melin-Aldana H, Ackerman SJ (2013) The oesophageal string test: a novel, minimally invasive method measures mucosal inflammation in eosinophilic oesophagitis. Gut 62:1395–1405PubMed

72.

Leung J, Hundal NV, Katz AJ, Shreffler WG, Yuan Q, Butterworth CA, Hesterberg PE (2013) Tolerance of baked milk in patients with cow’s milk-mediated eosinophilic esophagitis. J Allergy Clin Immunol 132:1215–1216 e1PubMedPubMedCentral

73.

Hirano I (2010) Dilation in eosinophilic esophagitis: to do or not to do? Gastrointest Endosc 71:713–714PubMed

74.

Cohen MS, Kaufman AB, Palazzo JP et al (2007) An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol 5:1149–1153PubMed

75.

Schoepfer AM, Gonsalves N, Bussmann C, Conus S, Simon HU, Straumann A, Hirano I (2010) Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 105:1062–1070PubMed

76.

Jensen ETMC, Kappelman MD, Dellon ES (2016) Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: estimates from a national administrative database. J Pediatr Gastroenterol Nutr 62:36–42PubMedPubMedCentral

77.

Talley NJSR, Phillips SF, Zinsmeister AR (1990) Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues. Gut 31:53

78.

Fouroughi SFB, Kim N (2007) Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol 120:594–601

79.

Min KUMD (1991) Eosinophilic gastroenteritis. Immunol Allergy Clin N Am 11:799

80.

Caldwell JHTJ, Bronstein HA (1975) Serum IgE in eosinophilic gastroenteritis. Response to intestinal challenge in two cases. N Engl J Med 292:1388PubMed

81.

Ko MHMR, Yershov O, Chehade M (2014) Eosinophilic gastritis in children: clinicopathologic correlation, disease course and response to therapy. Am J Gastroenterol 109:1277–1285

82.

Gonsalves NDB, Yang G, Hirano I (2009) A prospective clinical trial of six food elimination diet or elemental diet in the treatment of adults with eosinophilic gastroenteritis (abstract). Gastroenterology 136:S1861

83.

Prussin CLJ, Foster B (2009) Eosinophilic gastrointestinal disease and peanut allergy are alternatively associated with IL-5+ and IL-5(-) T(H)2 responses. J Allergy Clin Immunol 124:1326PubMedPubMedCentral

84.

Caldwell JMCM, Stucke EM, Putnam PE, Franciosi JP, Kushner JP, Abonia JP, Rothenberg ME (2014) Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, Th2immunity and a unique gastric transcriptome. J Allergy Clin Immunol 134:1114–1124PubMedPubMedCentral

85.

Yun MYCY, Park IS (2007) Eosinophilic gastroenteritis presenting as small bowel obstruction: a case report and review of the literature. World J Gastroenterol 13:1758–1760PubMedPubMedCentral

86.

Klein NCHR, Sleisenger MH, Jeffries GH (1970) Eosinophilic gastroenteritis. Medicine 49:299–320PubMed

87.

Cello JP (1979) Eosinophilic gastroenteritis—a complex disease entity. Am J Med 67:1097–1104PubMed

88.

Chang JYCR, Lee RM, Lock GR, Schleck CD, Zinsmeister AR, Smyrk TC, Talley NJ (2010) A shift in the clinical spectrum of eosinophilic gastroenteritis toward the mucosal disease type. Clin Gastroenterol Hepatol 8:669–675PubMed

89.

Katz AJGH, Grand RJ (1977) Gastric mucosal biopsy in eosinophilic (allergic) gastroenteritis. Gastroenterology 73

90.

MacCarty RLTN (1990) Barium studies in diffuse eosinophilic gastroenteritis. Gastrointest Radiol 15:183–187PubMed

91.

Chen MJCC, Lin SC (2003) Eosinophilic gastroenteritis: clinical experience with 15 patients. World J Gastroenterol 9:2813–2816PubMed

92.

Lee CMCC, Chen PC, Lin DY, Sheen IS, Wang CS, Tai DI, Sheen-Chen SM, Chen WJ, Wu CS (1993) Eosinophilic gastroenteritis: 10 years experience. Am J Gastroenterol 88:70–74PubMed

93.

Tan ACKJ, Naber TH (2001) Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets. Eur J Gastroenterol Hepatol 13:425–427PubMed

94.

Siewert ELF, Koppitz P (2006) Eosinophilic gastroenteritis with severe protein-losing enteropathy: successful treatment with budesonide. Dig Liver Dis 38:55–59PubMed

95.

Elsing CPJ, Gross-Weege W (2007) Budesonide for the treatment of obstructive eosinophilic jejunitis. Z Gastroenterol 45:187–189PubMed

96.

Van Dellen RGLJ (1994) Oral administration of cromolyn in a patient with protein-losing enteropathy, food allergy, and eosinophilic gastroenteritis. Mayo Clin Proc 69:441–444

97.

Melamed IFS, Sherman PM, Roifman CM (1991) Benefit of ketotifen in patients with eosinophilic gastroenteritis. Am J Med 90:310–314PubMed

98.

Prussin CJS, Huber MM (2003) Pilot study of anti-IL-5 in eosinophilic gastroenteritis (abstract). J Allergy Clin Immunol 11:a

99.

Chehade MMM, Mofidi S (2006) Allergic eosinophilic gastroenteritis with protein-losing enteropathy: intestinal pathology, clinical course, and long-term follow-up. J Pediatr Gastroenterol Nutr 42:516PubMed

Titel: Eosinophilic Gastrointestinal Disorders
verfasst von: Nirmala Gonsalves
Publikationsdatum: 22.03.2019
Verlag: Springer US
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 2/2019
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-019-08732-1

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Eosinophilic Gastrointestinal Disorders

Abstract

Neu im Fachgebiet HNO

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies

Nutritional Issues in Food Allergy

Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders

Supporting a Healthy Microbiome for the Primary Prevention of Eczema

Gastrointestinal Disorders Associated with Primary Immunodeficiency Diseases

Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review

Neu im Fachgebiet HNO

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

Update HNO